Digital pharmacy seeks to become the next Mexican unicorn
Jalisco is the leading consumer of online medicines at the national level. Therefore, the digital pharmacy Prixz seeks to consolidate operations in the Guadalajara metropolitan area and is on its way to becoming the next Mexican unicorn.
According to the platform’s Marketing Director, Erick Ramírez de Arellano, from January to June 2022, Prixz delivered more than 500,000 orders throughout the national territory, making it the online pharmacy with the most significant coverage in the country. Country and intends to become the new Mexican unicorn.
According to the manager, from 2019 to 2020, the company’s growth was 400%; from 2020 to 2021, it amounted to 700%, and in the first seven months of 2022, the platform grew 716% compared to the same period of the previous year.
However, in the case of Jalisco, the growth was higher from January to July of 2022; total sales grew by 2000%, while orders increased by 850% compared to the same period in 2021.
For his part, the finance director of the health tech, Javier Encino, commented to El Economista that in April of this year, Prixz completed a financing round with which it placed its valuation at just over 100 million dollars (add).
With this round of capital, the company seeks to consolidate itself as the most prominent digital health platform in Latin America, speed up the development of its distribution centers, and accelerate its growth in Mexico and Colombia”.
Not only are we well on our way to becoming the next Mexican unicorn…thanks to this round of financing, we will be able to expand our market throughout Mexico and enter other Latin American countries”, stressed the Director of Finance.
In an interview with this medium, Erick Ramírez, Director of Marketing, anticipated that in the first quarter of 2023, the company will look for the B series to continue the growth of the digital pharmacy, mainly in its distribution centers and in the acquisition of new technologies. To expedite drug delivery.
In addition to distributing pharmaceutical products, the technology company has several alliances that allow it to offer health services and 20,000 products, including controlled, cold chain, and highly specialized medicines, Erick Ramírez said.
In the first seven months of this year, Prixz made sales in 1,697 municipalities throughout the country; that is, in 69% of the total number of cities in Mexico, and the growth of its sales has been maintained at 30% per month.
The major issues for the further development of the pharmaceutical market will be discussed at the Mexican Pharmaceutical Forum that will be organized by the Global Pharmaceutical Leaders’ Club on the 29-30th November 2022 in Mexico City. Secure your delegate place ASAP! Registration is here: https://mexicanpharmaforum.com/registration/
Takeda appoints Hernán Porcile as its new General Manager in Mexico
October 24, 2022
Solid growth of the Medical Devices sector in Mexico
October 19, 2022
Sandoz Receives Certification for Transparent Practices
October 19, 2022